Payden & Rygel Investment Group’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$19.2M Sell
273,500
-22,100
-7% -$1.58M 1.55% 26
2024
Q1
$21.9M Buy
+295,600
New +$20.6M 1.03% 23
2023
Q3
$15.6M Buy
+248,300
New +$15.5M 1.07% 32

Other funds holding MET

Payden & Rygel Investment Group's MET Position: Q2 2024 in Review

Payden & Rygel Investment Group reduced its MetLife (MET) stake by 7.5% in Q2 2024, selling an estimated $1.58M and leaving 273,500 shares worth $19.2M. The position accounts for 1.55% of the portfolio, ranked #26.

Payden & Rygel Investment Group first reported a position in MET in Q3 2023 and has held it in 3 quarters since. The position peaked at $21.9M in Q1 2024. 1,295 funds tracked by Wall St. Rank hold MET as of Q2 2024.

  • Payden & Rygel Investment Group held 273,500 shares of MetLife worth $19.2M as of Q2 2024.
  • Payden & Rygel Investment Group sold 22,100 MetLife shares in Q2 2024, an estimated $1.58M.
  • MetLife made up 1.55% of Payden & Rygel Investment Group's portfolio in Q2 2024, its #26 holding.
  • Payden & Rygel Investment Group first reported a position in MetLife in Q3 2023 and has held it in 3 quarters since.
  • Payden & Rygel Investment Group's MetLife position peaked at $21.9M in Q1 2024.
  • 1,295 funds tracked by Wall St. Rank held MetLife as of Q2 2024.

Based on Payden & Rygel Investment Group's 13F filing for Q2 2024, filed 12 Aug 2024.